Intestinal epithelial barrier modulation

The term "intestinal epithelial barrier modulation" refers to the broad set of molecular mechanisms and signaling pathways that regulate the integrity, permeability, and function of the intestinal epithelial barrier. This barrier comprises epithelial cells joined by tight junctions, adherens junctions, and desmosomes, and selectively permits the absorption of nutrients while preventing the passage of pathogens and toxins. Modulation occurs via numerous proteins (e.g., claudins, occludin, myosin light chain kinase), signaling pathways (e.g., NF-κB, p38 MAPK, MEKK-1), transcription factors (e.g., ATF-2, Elk-1), and is strongly influenced by cytokines (like IL-1β, TNF-α), immune cells, and gut microbiota. Disruption or excessive modulation is implicated in diseases such as inflammatory bowel disease, celiac disease, and infections. Intestinal epithelial barrier modulation is a process, not a single target, and should not be listed as a canonical molecular entity. For structured databases, approaches should instead focus on specific molecules such as "Myosin light chain kinase" or "Claudin-2" or "Occludin" when referring to drug targets or biomarkers in this context.

Other names

Intestinal barrier modulationIntestinal epithelial tight junction modulationIntestinal permeability regulationGut barrier modulation

Not applicable as a single target; however, drugs may stabilize tight junctions, inhibit inflammatory signaling (e.g., NF-κB pathway), or reduce MLCK activity